Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is BioForce Nanosciences Holdings EV-to-EBIT?
BioForce Nanosciences HoldingsBFNH +0.80%32 EV-to-EBIT is -88.98 as of Jul. 26, 2026. GuruFocus rates BFNH with a GF Score™ of 32/100. The stock has 1 warning sign investors should review. Among 1,560 Consumer Packaged Goods companies, BioForce Nanosciences Holdings ranks worse than 64102.5% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
BioForce Nanosciences Holdings's Enterprise Value for the quarter that ended in Mar. 2026 was $11.73 Mil.
BioForce Nanosciences Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.48 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioForce Nanosciences Holdings EV-to-EBIT Related Terms
BioForce Nanosciences Holdings EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, BioForce Nanosciences Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioForce Nanosciences Holdings EV-to-EBIT vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, BioForce Nanosciences Holdings's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where BioForce Nanosciences Holdings's EV-to-EBIT falls into.
BioForce Nanosciences Holdings's current Enterprise Value is $42.27 Mil.
BioForce Nanosciences Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.48 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioForce Nanosciences Holdings (BFNH) has a EV-to-EBIT of -88.98 as of Jul. 26, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on BioForce Nanosciences Holdings and its competitors. According to the industry distribution chart, BioForce Nanosciences Holdings ranks #999999 out of 1560 companies in the Consumer Packaged Goods industry.
Is BioForce Nanosciences Holdings' EV-to-EBIT too high?
BioForce Nanosciences Holdings' current EV-to-EBIT is -88.98. Based on the distribution chart, BioForce Nanosciences Holdings ranks #999999 out of 1560 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, BioForce Nanosciences Holdings has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does BioForce Nanosciences Holdings' EV-to-EBIT compare to LSF and GWLL?
According to the Consumer Packaged Goods industry distribution chart, BioForce Nanosciences Holdings ranks #999999 out of 1560 companies for EV-to-EBIT. This places BioForce Nanosciences Holdings in the lower half of its industry. The industry median EV-to-EBIT is 11.97. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Consumer Packaged Goods company?
The median EV-to-EBIT among Consumer Packaged Goods companies is 11.97, based on 1,560 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on BioForce Nanosciences Holdings and its competitors. For the Consumer Packaged Goods industry, the median EV-to-EBIT is 11.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioForce Nanosciences Holdings's current EV-to-EBIT is -88.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioForce Nanosciences Holdings stock overvalued right now?
BioForce Nanosciences Holdings (BFNH) has a current EV-to-EBIT of -88.98. The current EV-to-EBIT is -88.98. BioForce Nanosciences Holdings' overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For BioForce Nanosciences Holdings (BFNH), the current EV-to-EBIT is -88.98 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BioForce Nanosciences Holdings Business Description
BioForce Nanosciences Holdings Inc is a provider of natural vitamins, minerals, and other nutritional supplements, powders, and beverages. It markets its products through social media and telemarketing. BioForce currently markets its products through social media and telemarketing. Nutrition retailers, grocery stores, retail pharmacies, and online stores, like Amazon, will be important channels for the Company's Eclipse product-lines.
32GF Score
Get the complete analysis for BFNH
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BFNH has been successfully added to your 
